Get access to our best features
Get access to our best features
Published

CoreMedic Partners With InnoRa for Development of ChordArt TMVr Device - Cardiac Interventions Today

Summary by Cardiac Interventions Today
January 17, 2025—CoreMedic GmbH recently announced it has entered into a strategic partnership with InnoRa GmbH to accelerate the clinical development of its ChordArt transcatheter mitral valve repair (TMVr) device. According to the company, the ChordArt TMVr system is designed to improve chorda repair procedures across all crucial parameters. These parameters include reduction of patient trauma, duration of procedure, complexity, operator depen…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)